Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial Redazione 15 Aprile 2021 ...
Modeling and targeting of erythroleukemia by hematopoietic genome editing Redazione 1 Aprile 2021 ...
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program Redazione 1 Aprile 2021 ...
Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study (938 Online Views) Redazione 1 Aprile 2021 ...
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico‐biological parameters Redazione 1 Aprile 2021 ...
The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making Redazione 1 Aprile 2021 ...
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study Redazione 18 Marzo 2021 ...
A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial Redazione 4 Marzo 2021 ...